Literature DB >> 10443972

Synthesis of a novel lipopeptide with alpha-melanocyte-stimulating hormone peptide ligand and its effect on liposome stability.

Y Ogawa1, H Kawahara, N Yagi, M Kodaka, T Tomohiro, T Okada, T Konakahara, H Okuno.   

Abstract

Introduction of liposomes into target cells is important for drug delivery systems. For this purpose, the surface of the liposome is equipped with ligand peptides, which may bind to specific receptors on the cell membrane. An artificial novel lipopeptide (MSH-C4A2) containing the alpha-melanocyte-stimulating hormone (alpha-MSH) sequence and two long alkyl chains was designed and synthesized, and the liposome, composed of egg phosphatidylcholine (EPC) and MSH-C4A2, was prepared. The stability of the liposome was estimated by measuring calcein leakage from the liposome inner phase. The stability of the liposome decreased upon addition of MSH-A4C2, which seemed to be attributable to the amphiphilic property of the peptide moiety (alpha-MSH) of MSH-A2C4. The stability was, however, recovered fairly well upon addition of cholesterol (Ch) or phosphatidylglycerol (PG). It was concluded therefore that the ternary system, MSH-C4A2/Ch/EPC or MSH-C4A2/PG/EPC, is suitable for preparing the functional liposome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443972     DOI: 10.1007/s11745-999-0377-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  22 in total

1.  Semiautomated T-bag peptide synthesis using 9-fluorenyl-methoxycarbonyl strategy and benzotriazol-1-yl-tetramethyl-uronium tetrafluoroborate activation.

Authors:  A G Beck-Sickinger; H Dürr; G Jung
Journal:  Pept Res       Date:  1991 Mar-Apr

2.  Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells.

Authors:  J M Varga; N Asato; S Lande; A B Lerner
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

Review 3.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.

Authors:  G B Fields; R L Noble
Journal:  Int J Pept Protein Res       Date:  1990-03

4.  Structure of aqueous mixtures of lecithin and cholesterol.

Authors:  H Lecuyer; D G Dervichian
Journal:  J Mol Biol       Date:  1969-10-14       Impact factor: 5.469

5.  Molecular motion in spin-labeled phospholipids and membranes.

Authors:  W L Hubbell; H M McConnell
Journal:  J Am Chem Soc       Date:  1971-01-27       Impact factor: 15.419

6.  pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs.

Authors:  J Connor; L Huang
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

7.  Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.

Authors:  A Gabizon; A Dagan; D Goren; Y Barenholz; Z Fuks
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

8.  Automated solid-phase peptide synthesis: use of 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate for coupling of tert-butyloxycarbonyl amino acids.

Authors:  G E Reid; R J Simpson
Journal:  Anal Biochem       Date:  1992-02-01       Impact factor: 3.365

9.  Stability and pH sensitivity of sulfatide-containing phosphatidylethanolamine small unilamellar vesicles.

Authors:  X Wu; K H Lee; Q T Li
Journal:  Biochim Biophys Acta       Date:  1996-10-02

10.  HBTU activation for automated Fmoc solid-phase peptide synthesis.

Authors:  C G Fields; D H Lloyd; R L Macdonald; K M Otteson; R L Noble
Journal:  Pept Res       Date:  1991 Mar-Apr
View more
  5 in total

1.  Lipid analog with 2-nitrophenol trigger designed for liposome fusion at physiological pH.

Authors:  S N Shah; T Tomohiro; Y Ogawa; M Kodaka; H Okuno
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

2.  Preparation of functional liposomes with peptide ligands and their binding to cell membranes.

Authors:  N Yagi; Y Ogawa; M Kodaka; T Okada; T Tomohiro; T Konakahara; H Okuno
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

Review 3.  Malignant melanoma and melanocortin 1 receptor.

Authors:  A A Rosenkranz; T A Slastnikova; M O Durymanov; A S Sobolev
Journal:  Biochemistry (Mosc)       Date:  2013-11       Impact factor: 2.487

4.  Targeted drug delivery utilizing protein-like molecular architecture.

Authors:  Evonne M Rezler; David R Khan; Janelle Lauer-Fields; Mare Cudic; Diane Baronas-Lowell; Gregg B Fields
Journal:  J Am Chem Soc       Date:  2007-03-31       Impact factor: 15.419

5.  Camptothecin-Loaded Liposomes with α-Melanocyte-Stimulating Hormone Enhance Cytotoxicity Toward and Cellular Uptake by Melanomas: An Application of Nanomedicine on Natural Product.

Authors:  Chih-Hung Lin; Saleh A Al-Suwayeh; Chih-Feng Hung; Chih-Chieh Chen; Jia-You Fang
Journal:  J Tradit Complement Med       Date:  2013-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.